European and worldwide projects
Some examples of projects we execute with European and overseas partners:
MINDMAP:
We investigate the importance of the living environment for health and well-being through large European cross-city studies
SEFAC:
Proactive and self-empowering preventive programmes. For example, the aim of the Social Engagement Framework for Addressing the Chronic disease challenge (SEFAC) project is to reduce the burden of individuals with a chronic condition, and increase sustainability of the health system by supporting self-management.
The CanScreen-ECIS project.
This project aims to develop and pilot a new cancer screening data management system to be integrated into the existing European Cancer Information System (ECIS). The project is a collaboration with European experts involved in two other key projects on cancer screening data collection: the second European Screening Report (EUSR) and EU-TOPIA.
CANCER SURVEILLANCE:
We are the national evaluation unit for the Dutch screening programmes on breast, cervical and colorectal cancer, and we evaluate programmes in the EU, the US and worldwide. Guiding public health policies on screening, using predictions of the favourable and unfavourable effects and cost of screening, based on micro-simulation modelling (MISCAN). Examples include the United States guidelines for breast, colorectal and lung cancer screening.
EU-TOPIA:
To improve health outcomes and equity of breast, cervical and colorectal cancer screening programmes in ways that take full account of the different demographical, medical, political, economic and cultural contexts across Europe. We aim to do so by providing national, regional, and local policymakers with tools to evaluate and quantify their cancer screening programmes
4-IN-THE-LONG-RUN:
the overall aim of the project is to optimise CT lung cancer screening by evaluating the comparative (cost-) effectiveness of existing (and innovative) approaches to provide significant evidence for health care systems implementation of personalised lung cancer screening following the positive results of the NELSON trial
Infectious diseases remain an important global public health problem, especially in developing countries. Our main research activities cover neglected tropical diseases (NTDs), including various helminth (worm) infections, leishmaniasis and leprosy, as well as tuberculosis, malaria and HIV/AIDS. We collaborate internationally with scientific, governmental and non-governmental organizations to support international control and elimination programmes for these infectious diseases. We also study infectious diseases common in migrant populations in Rotterdam, as well as hand hygiene in health care settings. Our research methodologies include mathematical modelling, epidemiological data analysis, and behavioural studies.
EUCanScreen
- Project Summary
European Joint Action on Cancer Screening (EUCanScreen – project ID number 101162959) is a project with the aim to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancer as well as implementation of the recently recommended screening programs for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
The project consortium consists of 97 partners (29 competent authorities, 61 affiliated partners, and 7 associated partners) from 29 countries. The Department of Public Health of Erasmus MC is an affiliated entity in the project and its role is leading Work Package 10 which is about modelling and health technology assessment to optimize cancer screening programmes across Europe. The overall objective of this Work Package is to optimize and prioritise existing and new screening programmes.
The project’s duration is 48 months from 1 June 2024 until 31 May 2028 and the total funding amount is 38.749.935 euros.
- Coordinator contact details:
University of Latvia (Latvijas Universitāte) screening@lu.lv
List of participants:
Competent Authorities:
1.UNIVERSITY OF LATVIA (LU)
2.GESUNDHEIT OSTERREICH GMBH (AT)
3.SCIENSANO (BE)
4.HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (HR)
5.Ministry of Health of the Republic of Cyprus (CY)
6.USTAV ZDRAVOTNICKYCH INFORMACI A STATISTIKY CESKE REPUBLIKY (CZ)
7.REGION SYDDANMARK (DK)
8.TERVISE ARENGU INSTITUUT (EE)
9.TERVEYDEN JA HYVINVOINNIN LAITOS (FI)
10.INSTITUT NATIONAL DU CANCER GIP (FR)
11.ROBERT KOCH-INSTITUT (DE)
12.MINISTRY OF HEALTH (EL)
13.ORSZAGOS KORANYI PULMONOLOGIAI INTEZET (HU)
14.HEILSUGAESLA HOFUDBORGARSVAEDISINS (IS)
15.DEPARTMENT OF HEALTH (IE)
16.ISTITUTO PER LO STUDIO E LA PREVENZIONE E LA RETE ONCOLOGICA (IT)
17.LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (LT)
18.Ministry for Health and Active Ageing – Government of Malta (MT)
19.INSTITUTIA MEDICO-SANITARA PUBLICA INSTITUTUL ONCOLOGIC (MD)
20.RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL)
21.HELSEDIREKTORATET (NO)
22.NARODOWY INSTYTUT ONKOLOGII IM. MARII SKLODOWSKIEJ-CURIE – PANSTWOWY INSTYTUT BADAWCZY (PL)
23.MINISTERIO DA SAUDE – REPUBLICA PORTUGUESA (PT)
24.INSTITUTUL NATIONAL DE SANATATE PUBLICA (RO)
25.MINISTERSTVO ZDRAVOTNICTVA SLOVENSKEJ REPUBLIKY (SK)
26.ONKOLOSKI INSTITUT LJUBLJANA (SI)
27.INSTITUT CATALA D’ONCOLOGIA (ES)
28.SOCIALSTYRELSEN (SE)
29.STATE INSTITUTION PUBLIC HEALTH CENTER OF THE MINISTRY OF HEALTH OF UKRAINE (UA)
Affiliated Entities:
1. SLIMĪBU PROFILAKSES UN KONTROLES CENTRS (LV)
2. RĪGAS STRADIŅA UNIVERSITĀTE (LV)
3. PAULA STRADIŅA KLĪNISKĀ UNIVERSITĀTES SLIMNĪCA (LV)
4. UNIVERSITAT FUR WEITERBILDUNG KREMS (AT)
5. UMIT TIROL – PRIVATE UNIVERSITAT FUR GESUNDHEITSWISSENSCHAFTEN UND TECHNOLOGIE GMBH (AT)
6. CENTRUM VOOR KANKEROPSPORING (BE)
7. STICHTING KANKERREGISTER – FONDATION REGISTRE DU CANCER (BE)
8. CENTRE COMMUNAUTAIRE DE REFERENCE POUR LE DEPISTAGE DES CANCERS (BE)
9. UNIVERSITAIR ZIEKENHUIS ANTWERPEN (BE)
10. CENTRE BRUXELLOIS DE COORDINATION POUR LE DEPISTAGE ET LA PREVENTION DES CANCERS (BE)
11. KLINICKI BOLNICKI CENTAR ZAGREB (HR)
12. UNIVERSITY OF CYPRUS (CY)
13. TARTU ULIKOOL (EE)
14. SUOMEN SYOPAYHDISTYS – CANCERFORENINGEN I FINLAND RY – CANCER SOCIETY OF FINLAND CSF (FI)
15. FEDERATION HOSPITALIERE DE FRANCE (FR)
16. HOSPICES CIVILS DE LYON (FR)
17. UNICANCER (FR)
18. ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (FR)
19. PLATEFORME DES DONNEES DE SANTE (FR)
20. DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (DE)
21. LEIBNIZ-INSTITUT FUR PRAVENTIONSFORSCHUNG UND EPIDEMIOLOGIE – BIPS GMBH (DE)
22. DEUTSCHE KREBSGESELLSCHAFT EV (DE)
23. DIOIKISI 6IS YGEIONOMIKIS PERIFEREIAS PELOPONNISOU IONION NYSON IPEIROU KAI DYTIKIS ELLADAS (EL)
24. NEMZETI NEPEGESZSEGUGYI ES GYOGYSZERESZETI KOZPONT (HU)
25. LANDLAEKNIS EMBAETTID (IS)
26. HEALTH SERVICE EXECUTIVE (IE)
27. ROYAL COLLEGE OF SURGEONS IN IRELAND (IE)
28. ISTITUTO SUPERIORE DI SANITA (IT)
29. MINISTERO DELLA SALUTE (IT)
30. AZIENDA UNITA SANITARIA LOCALE DI REGGIO EMILIA (IT)
31. REGIONE MARCHE (IT)
32. AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO (IT)
33. AZIENDA ULSS 4 VENETO ORIENTALE (IT)
34. ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (IT)
35. UNIVERSITA CATTOLICA DEL SACRO CUORE (IT)
36. PROVINCIA AUTONOMA DI TRENTO (IT)
37. FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI (IT)
38. REGIONE LOMBARDIA (IT)
39. ATS PAVIA (IT)
40. VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS (LT)
41. LIETUVOS SVEITAKOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS (LT)
42. ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (NL)
43. STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM (NL)
44. STICHTING BEVOLKINGSONDERZOEK NEDERLAND (NL)
45. FOLKEHELSEINSTITUTTET (NO)
46. INSTYTUT GRUZLICY I CHOROB PLUC (PL)
47. INSTITUTO PORTUGUES DE ONCOLOGIA DO PORTO FRANCISCO GENTIL, EPE (PT)
48. UNIDADE LOCAL DE SAUDE DE SAO JOAO, E.P.E. (PT)
49. UNIDADE LOCAL DE SAÚDE SANTA MARIA (PT)
50. INSTITUTUL CLINIC FUNDENI (RO)
51. INSTITUTUL ONCOLOGIC PROF DR ION CHIRICUTA CLUJ-NAPOCA (RO)
52. NARODNY ONKOLOGICKY USTAV (SK)
53. NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (SI)
54. ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SISTEMAS DE SALUD-BIOSISTEMAK (ES)
55. FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (ES)
56. INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (ES)
57. FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA (ES)
58. FUNDACIO INSTITUT HOSPITAL DEL MAR D INVESTIGACIONS MEDIQUES (ES)
59. SVERIGES KOMMUNER OCH REGIONER (SE)
60. STATE INSTITUTION VOZIANOV INSTITUTE OF UROLOGY OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE (UA)
61. NATIONAL CANCER INSTITUTE (UA)
Associated Partners:
1. INSTITUT JULES BORDET ASBL (BE)
2. MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT (NL)
3. INSTITUTO TUMORI “GIOVANNI PAOLO II” IRCCS (IT)
4. AZIENDA SANITARIA LOCALE TARANTO (IT)
5. MSB MEDICAL SCHOOL BERLIN GMBH (DE)
6. CENTRUL NATIONAL DE SANATATE MINTALA SI LUPTA ANTODROG (RO)
7. INSTITUTUL REGIONAL DE ONCOLOGIE IASI (RO)
- Project results
Will be updated after the end of the project.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no. 101162959
